SEARCH · PubMed Health

Results for “Phacoemulsification”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 307 records · Page 17Linked to original sources

PubMed2005

Prospective evaluation of phacoemulsification in adults younger than 50 years.

PURPOSE: To evaluate intraoperative performance and long-term outcome of phacoemulsification in patients younger than 50 years. SETTING: Iladevi cataract and IOL Research Centre, Ahmedabad, India. METHODS: A prospective observational study was conducted comprising 54 patients (35 men and 19 women) under age 50 who had phacoemulsification. Preoperative evaluation included specular microscopy. Phacoemulsification with implantation of an AcrySof MA30BA intraocular lens (IOL) was performed. Intraoperatively, peripheral extension of capsulorhexis, intraoperative posterior capsule opacification (PCO; plaque), and serious complications (eg, posterior capsule rupture, vitreous loss) were noted. Postoperatively, endothelial cell loss, postoperative PCO, neodymium:YAG (Nd:YAG) laser posterior capsulotomy rate, and best corrected visual acuity (BCVA) were assessed for 3 years. Patients with intraoperative PCO were analyzed separately. RESULTS: Mean patient age was 42.7 years +/- 5.2 SD (men) and 43.1 +/- 3.25 years (women). Continuous curvilinear capsulorhexis was achieved in 49 patients (90.7%). Intraoperative PCO was present in 14 (25.92%) patients. An Nd:YAG laser posterior capsulotomy was performed in 4 patients (28.5%). Posterior capsule rupture leading to vitreous loss occurred in 1 patient (1.85%). At 3-year follow-up, endothelial cell loss was 5.9%. Postoperative PCO developed in 8 patients (22.2%), and Nd:YAG laser posterior capsulotomy was performed in 5 patients (13.8%). The BCVA was > or = 20/40 in 47 patients (94%). CONCLUSION: Young patients pose a challenge in creating a capsulorhexis and display significant incidence of intraoperative and postoperative PCO.

Adult↗

PubMed2005

Randomized comparative clinical study of cryoanalgesia versus topical anesthesia in clear corneal phacoemulsification.

PURPOSE: To compare intraoperative pain scores and objective stress signs during clear corneal phacoemulsification under cryoanalgesia and topical anesthesia. SETTING: Hospital Ramón y Cajal, Madrid, and Hospital Universitario Nuestra Sra. de la Candelaria, Tenerife, Canary Islands, Spain. METHODS: Eighty-two patients were randomized to have phacoemulsification under cryoanalgesia or topical anesthesia. Uncooperative patients and those with shallow anterior chamber and small pupils were excluded. In case of breakthrough pain during the surgery, a supplemental anesthesia protocol was established. Each patient was asked to grade the severity of pain on a 4-point scale (verbal description score; 0=none, 1=little, 2=some, or 3=much). Immediately after surgery, the general discomfort and pain were evaluated. Surgeon stress was evaluated during surgery. A comparison of the 2 groups was performed using a statistical analysis of variance. RESULTS: Supplemental anesthesia was required in 1 patient in each group. A total of 95.23% of patients would repeat the same technique under cryoanalgesia versus 97.5% under topical anesthesia. Similar pain levels and surgical stress scores were noted in both groups. CONCLUSIONS: Cryoanalgesia clear corneal phacoemulsification was safe with an acceptable level of pain. It induced a physiological stress response to that of topical anesthesia (blood pressure and heart rate). Cryoanalgesia was preferred over topical anesthesia by some patients. It is a suitable technique for anesthetic allergy cases.

Adult↗

PubMed2005

Safety of trypan blue 1% and indocyanine green 0.5% in assisting visualization of anterior capsule during phacoemulsification in mature cataract.

PURPOSE: To evaluate the safety of trypan blue 1% and indocyanine green (ICG) 0.5% in assisting visualization of anterior capsule during phacoemulsification in mature cataract. SETTING: Department of Ophthalmology, United Christian Hospital, Hong Kong, China. METHODS: This prospective randomized clinical trial comprised 46 eyes with mature cataract receiving phacoemulsification and posterior chamber intraocular lens implantation. They were randomized into 3 groups (trypan blue, ICG, and control without stain). Visual acuity, endothelial cell count, corneal clarity, anterior chamber reaction, and intraocular pressure (IOP) were documented before surgery and 1 week, 1 month, and 3 months postoperatively. The absolute phaco time was also recorded. RESULTS: There was no significant difference in absolute phaco time (P=.17), mean endothelial cell loss (P=.72 at 1 week, P=.43 at 1 month, and P=.60 at 3 months) and no significant correlation between the absolute phaco time and the change in endothelial cell count (P=.50 at 1 week, P=.10 at 1 month, and P=.60 at 3 months) in the 3 groups. None of the patients had postoperative IOP greater than 21 mm Hg. All eyes had clear corneas and a quiet anterior chamber 3 months after surgery. CONCLUSION: Both trypan blue 1% and ICG 0.5% are safe for assisting visualization of the anterior capsule during phacoemulsification of mature cataract.

Capsulorhexis↗

PubMed2005

Sequential argon-YAG laser membranectomy and phacoemulsification for treatment of persistent pupillary membrane and associated cataract.

We report a case of a persistent pupillary membrane (PPM) associated with a cataract managed by sequential argon-YAG laser membranectomy and phacoemulsification. A 30-year-old woman had an extensive PPM and anterior capsular opacity of the lens in the right eye. Best corrected visual acuity (BCVA) was 20/60. Argon laser photocoagulation was performed at the junction of the PPM and the iris collarette. Subsequently, a neodymium:YAG laser was used to sever the strands of the PPM. These laser procedures resulted in shrinkage of the PPM without hemorrhage in the iris or other complications. The patient had clear corneal sutureless phacoemulsification uneventfully on the next day. The BCVA improved to 20/25 3 months following the treatment. We conclude that combined sequential argon-YAG laser membranectomy and modern phacoemulsification surgery can effectively be used to treat PPM associated with cataract without bleeding of the iris or other major side effects.

Adult↗

PubMed2005

In-air thermal imaging comparison of Legacy AdvanTec, Millennium, and Sovereign WhiteStar phacoemulsification systems.

PURPOSE: To compare the temperature profiles of 3 popular phacoemulsification units (Alcon Legacy AdvanTec, Bausch & Lomb Millennium, and AMO Sovereign WhiteStar) under similar operating conditions in air. SETTING: Jules Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. METHODS: Phacoemulsification probes from the 3 units were placed side by side in air and imaged in the infrared region using model P60 ThermaCAM (Flir Systems). The highest temperature produced by each probe was measured 10 seconds and 30 seconds after power application. Testing was performed under conditions that might produce a corneal burn during cataract surgery. Irrigation flow was set at the low rate of 1 cc/min to simulate a tight incision. Aspiration flow was set at 0 cc/min to simulate occlusion of the needle lumen. Wound compression was simulated in some tests by suspending 22.6 g weights by rubber bands from the silicone sleeves. Manufacturers' specific and identical silicone sleeves were used to evaluate possible variations in thermal conductivity. The AdvanTec Legacy and Millennium were operated in pulse mode at 15 Hertz; 50% duty cycle; and 10%, 30%, and 50% power. The Sovereign WhiteStar was operated in both C/F (56 Hz, 33% duty cycle) and C/L (33 Hz, 20% duty cycle) modes at the same console power settings. Temperature profiles were determined at a variety of power settings with each system operating in continuous and pulse mode. RESULTS: Under all experimental conditions (at 10%, 30%, and 50% powers; with and without external weights suspended from the phacoemulsification probes; with manufacturers' and identical silicone sleeves; and in continuous and pulse modes), the Millennium and the Sovereign WhiteStar generated higher temperatures than the Legacy AdvanTec. CONCLUSIONS: Under controlled operating conditions in air and under a variety of power, load, and duty-cycle settings, the Millennium and the Sovereign WhiteStar, operating in both pulse and continuous modes, generated higher peak temperatures than the Legacy AdvanTec.

Air↗

PubMed2006

Pseudophakic retinal detachment after phacoemulsification cataract surgery: Ten-year retrospective review.

PURPOSE: To determine the risk for rhegmatogenous retinal detachment (RRD) after phacoemulsification. SETTING: Private and public facility, Auckland, New Zealand. METHODS: A retrospective study of 1793 consecutive patients having cataract surgery by phacoemulsification was performed. Patients younger than 40 years were excluded, as were patients who had cataract surgery after ocular trauma. Patients having cataract surgery combined with other ocular procedures such as keratoplasty, glaucoma drainage surgery, or posterior segment surgery were similarly excluded. RESULTS: Rhegmatogenous retinal detachment occurred in 1.17% of the patients having cataract surgery. The risk was greater in patients younger than 50 years (5.17%) and less in those older than 70 years (0.64%). The median interval between cataract surgery and development of the retinal detachment was 39 months. The rate of retinal detachment was greater with complicated cataract surgery, but there was no increased risk for those eyes requiring neodymium:YAG laser capsulotomy. CONCLUSIONS: The overall risk for RRD after cataract surgery by phacoemulsification was small. However, in the younger patient, the risk for pseudophakic detachment was higher. In light of this finding, the requirement for cataract surgery in this group should be reassessed.

Adult↗

PubMed2006

Surgically induced astigmatism after phacoemulsification in eyes with mild to moderate corneal astigmatism: temporal versus on-axis clear corneal incisions.

PURPOSE: To determine whether there is a difference in surgically induced astigmatism (SIA) and postoperative uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) between 2 types of clear corneal incisions used in phacoemulsification: the temporal and the on-axis (ie, on the steeper corneal meridian) clear corneal incision (CCTI and CCOI, respectively). SETTING: Moorfields Eye Hospital, London, United Kingdom. METHODS: In a prospective randomized controlled trial (pilot study), 61 eyes with cataract and mild to moderate corneal astigmatism (<2.58 diopters [D] on corneal topography) having phacoemulsification (single surgeon, 3.2 mm incision) were randomized to receive CCTI or CCOI. Main outcome measures included postoperative BCVA and corneal astigmatism and SIA (calculated using the Holladay vector analysis formula). Measurements were repeated postoperatively at 3 weeks in all eyes, whereas only 46 eyes made it to the final assessment at 8 weeks. Continuous variables between groups were compared by Student t test. The power of the study was calculated. RESULTS: At the first follow-up, the difference in SIA between the 2 incision types was 0.15 D and it was not statistically significant (0.65 D in CCOI; 0.50 D in CCTI). At the second follow-up, the difference was 0.29 D and it was statistically significant (0.63 D in CCOI; 0.34 D in CCTI; P = .0004). There was no statistically significant difference in the final postoperative visual acuity. The power of the pilot study was 72%. CONCLUSION: Seven weeks after small-incision phacoemulsification, the CCTI induced less SIA than the CCOI; however, there were no significant differences in the final UCVA and BCVA.

Aged↗

PubMed2006

Change in intraocular pressure within 1 week of phacoemulsification and intraocular lens implantation using Adatocel.

PURPOSE: To examine the change in intraocular pressure (IOP) within 1 week of phacoemulsification and foldable posterior chamber intraocular lens (PC IOL) implantation using Adatocel (hydroxypropyl methylcellulose 2% [HPMC]). SETTING: Department of Ophthalmology, University of Sciences, Faculty of Medicine, Pécs, Hungary. METHODS: In this prospective study, the IOP in 118 eyes of 118 patients (57 men, 61 women, mean age 68 years +/- 7.8 [SD]) with no history of glaucoma was assessed by Goldmann applanation tonometry 2 to 3, 6 to 8, and 22 to 24 hours and 1 week after uneventful phacoemulsification and PC IOL implantation. The effect of the removal of Adatocel ("partial removal" from the anterior chamber [AC] only versus "complete removal" from behind of the IOL as well), the lens type (Medicontur 601 HP versus Bausch & Lomb Hydroview), and the type of anesthesia (topical versus parabulbar) were compared. Statistical analysis was performed using the Student t test, and P< or =.05 was considered statistically significant. RESULTS: The mean preoperative IOP was 13.83 +/- 2.5 mmHg. There were no significant differences at any time in postoperative IOP measurements between the 2 IOL types and the 2 modes of anesthesia. At 2 to 3 hours, 6 to 8 hours, and 22 to 24 hours, the IOP was significantly higher in the 30 eyes in which the Adatocel was partially removed (from the AC only) than in the 88 eyes in which it was completely removed (from behind the PC IOL as well) (P< or =.05, P< or =.01, and P< or =.001, respectively). CONCLUSION: Severe postoperative IOP spikes in nonglaucomatous patients after uneventful phacoemulsification cataract surgery are rare. The type of implanted PC IOL and the mode of anesthesia had no significant effect on postoperative IOP. Total removal of the ophthalmic viscosurgical device, even when using HPMCs such as Adatocel, is necessary to prevent postoperative IOP spikes.

Adult↗

PubMed2006

Early post-phacoemulsification hypotony as a risk factor for intraocular contamination: in vivo model.

PURPOSE: To observe cataract wound dynamics and determine the risk for intraocular contamination under induced conditions of early postoperative hypotony after anterior chamber decompression for high intraocular pressure (IOP) spikes after uneventful phacoemulsification surgery. SETTING: Department of Ophthalmology, Queen's Hospital, Burton-on-Trent, United Kingdom. METHODS: In a prospective case series, 30 patients were treated with anterior chamber decompression for elevated IOP (>35 mm Hg) 1 to 2 hours after uneventful phacoemulsification through clear corneal temporal incisions. A drop of 2% fluorescein was instilled in the conjunctival sac before aqueous release to study the ocular fluid movements during and after the decompression procedure. The patterns of fluorescein movement were observed and photographed under cobalt blue light. RESULTS: Fluorescein staining of the entire corneal tunnel was observed in all 30 eyes after decompression. An immediate fluorescein flare was observed in the anterior chamber after aqueous release in 24 eyes (80%) (P<.001). Observations over several seconds after decompression found a frank influx of fluorescein-stained fluid into the anterior chamber in 12 eyes (40%) (P<.001), giving rise to an "inverse Seidel's test." An intermittent ingress of fluorescein-stained fluid continued for several minutes after the procedure in 6 eyes (20%) (P<.05). CONCLUSIONS: An incompetence of clear corneal cataract wound with intraocular contamination was observed during the period of induced hypotony after anterior chamber decompression in the early post-phacoemulsification period.

Aged↗

PubMed2006

Effects of pupil stretch technique during phacoemulsification on postoperative vision, intraocular pressure, and inflammation.

PURPOSE: To determine whether pupil stretch during phacoemulsification affects postoperative best corrected visual acuity (BCVA), intraocular pressure (IOP), and inflammation compared with results in patients without pupil stretch. METHODS: A retrospective analysis of 115 eyes that had pupil stretch during phacoemulsification (study group) and 125 eyes without pupil stretch (control group) was performed with a minimum of 12 months follow-up. Single-factor analysis of variance and 2-tailed homoscedastic t tests were used for statistical analysis. RESULTS: The mean preoperative logMAR equivalent BCVA was 0.5 +/- 0.3 (SD) in the study group and 0.6 +/- 0.4 in the control group. The mean preoperative IOP was 16.2 +/- 4.1 mm Hg in the study group and 16.0 +/- 3.5 mm Hg (control group). There was no statistically significant difference at postoperative follow-up of 1 year in BCVA or IOP between the 2 groups (1 year BCVA 0.2 +/- 0.2 [study group], 0.2 +/- 0.2 [control group] [P<.1]; IOP 14.5 +/- 3.5 mm Hg and 14.7 +/- 3.3 mm Hg, respectively [P<.7]). There was no significant difference in the number of glaucoma medications required for glaucoma patients preoperatively and postoperatively between the 2 groups (P<.5). Complications were rare, and there was no significant difference in the complications (ie, iritis, hyphema, cystoid macular edema, epiretinal membrane formation) between the 2 groups at 1 year. CONCLUSION: Pupil stretch during phacoemulsification was not associated with a statistically significant difference in BCVA, IOP, inflammation, or other complications postoperatively compared with results in the control group without pupil stretch.

Antihypertensive Agents↗

PubMed2006

Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study.

PURPOSE: To determine the incidence of diabetic retinopathy (DR) progression after phacoemulsification in patients with type II diabetes. SETTING: Service of Ophthalmology, University of Sant Joan, Barcelona, Spain. METHODS: This prospective study evaluated 132 patients with diabetes mellitus who had monocular phacoemulsification. A control group comprised the patients' contralateral eyes. Data analysis included preoperative retinal findings and DR status; hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and triglycerides levels; insulin treatment; and arterial hypertension. RESULTS: Postoperative visual acuity increased by 2 or more lines in 105 patients (79.55%); the mean postoperative acuity was 0.63 +/- 0.28 (SD). Diabetic retinopathy in the operated eye progressed in 31 patients (23.48%) and in the fellow eye in 28 patients (21.21%). The progression was associated with high levels of HbA1c and diabetes mellitus duration in both groups. Diabetic macular edema occurred in the operated eye in 8 patients (6.06%) and in the fellow eye in 6 patients (4.54%). Pseudophakic macular edema developed in 2 eyes (1.52%). The progression of diabetic macular edema was not associated with the risk factors studied. CONCLUSION: Uneventful phacoemulsification cataract surgery may not cause DR progression.

Aged↗

PubMed2006

Phacoemulsification in patients with Baerveldt tube shunts.

PURPOSE: To investigate the effects of phacoemulsification in glaucomatous eyes with functioning Baerveldt tube shunts. SETTING: Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. METHODS: This retrospective analysis followed 9 eyes of 8 patients with functioning Baerveldt tube shunts who had clear corneal phacoemulsification. Intraocular pressure (IOP), number of glaucoma medications, corneal thickness, visual acuity, and additional glaucoma surgery were measured. RESULTS: The mean follow-up was 21 months +/- 3 (SD) (range 17 to 25 months). The mean change in IOP and the number of glaucoma medications used did not significantly change at 1 month (P>.19), 1 year (P>.17), or the last follow-up (P>.17). At the last examination, 2 eyes had IOP increases of 2 to 4 mm Hg, 3 eyes had no change, and 4 eyes had decreases of 4 to 7 mm Hg. Intraocular pressure increased in 1 eye at 8 months and required a tube shunt revision. No eye developed corneal decompensation. Visual acuity improved in 8 eyes; the mean improvement was 4 +/- 3 Snellen lines. CONCLUSION: In most cases, phacoemulsification in glaucomatous eyes with a functioning Baerveldt tube shunt improved vision and maintained control of IOP.

Adult↗

PubMed2006

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.

PURPOSE: To assess the clinical benefit, relative efficacy, and pharmacokinetic-response curve of preoperative and postoperative ketorolac tromethamine 0.4% (Acular LS) to improve outcomes during and after cataract surgery. SETTING: Private clinical practice. METHODS: One hundred patients were randomized in a double-masked fashion to 4 groups of 25 to receive ketorolac for 3 days, 1 day, or 1 hour or a placebo before phacoemulsification. All treatment groups received ketorolac 0.4% for 3 weeks postoperatively; the placebo group received vehicle. Outcomes measures were preservation of preoperative mydriasis, phacoemulsification time and energy, operative time, corneal clarity, endothelial cell counts, postoperative inflammation, intraoperative and postoperative discomfort, complications, and incidence of clinically significant cystoid macular edema (CME). RESULTS: Maintenance of pupil size with 3-day ketorolac dosing was significantly better than with 1-day dosing (P<.01), which was significantly better than with 1-hour or placebo dosing (P<.01). Both 3-day and 1-day dosing were superior to 1-hour or placebo dosing. No patient receiving ketorolac 0.4% for 1 or 3 days developed CME compared with 12% of patients in the control (placebo) group and 4% in the 1-hour group. Three-day and 1-day dosing of ketorolac reduced surgical time, phacoemulsification time and energy, and endothelial cell loss and improved visual acuity in the immediate postoperative period compared with 1-hour predosing and the placebo (P<.05). CONCLUSION: The preoperative use of ketorolac tromethamine 0.4% for 3 days followed by 1-day of predosing provided optimum efficacy and superior outcomes relative to 1-hour pretreatment and a placebo.

Aged↗

PubMed2006

Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification.

PURPOSE: To investigate the efficacy of sutureless pars plana vitrectomy (PPV) combined with intracameral triamcinolone stain in the management of vitreous loss associated with phacoemulsification. SETTING: Department of Ophthalmology, Tri-Service General Hospital, Taipei, Taiwan, Republic of China. METHODS: This retrospective review comprised the charts of 21 patients who had sutureless PPV combined with intracameral triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification. The charts were analyzed for type of cataract, posterior segment pathology, methods of anesthesia, intraocular lens (IOL) placement, postoperative visual acuity, intraocular pressure, and complications. Additional outcome measurements were duration of the surgical procedures, period of postoperative corneal edema, and time to achieve stable vision. RESULTS: Excluding 2 eyes with preexisting conditions, 18 of 19 eyes (94.7%) had a final best corrected visual acuity (BCVA) of 20/40 or better and 42.1% (8/19) had a final BCVA of 20/20 or better. The mean duration of the surgery was 25.3 minutes (range 16 to 40 minutes). Corneal edema was noted in 12 eyes (57.1%) 3 days postoperatively and 3 eyes (14.3%) at 7 days. Eleven eyes (52.4%) had stable vision at 1 week, and 16 eyes (76.2%) had stable vision within 1 month postoperatively. Four eyes (19.0%) had postoperative complications that included a displaced IOL in 3 eyes (14.3%) and cystoid macular edema in 1 eye (4.8%). CONCLUSIONS: Self-sealing, sutureless PPV combined with intracameral triamcinolone stain was a safe, reliable adjunct to manage vitreous loss during phacoemulsification. The surgery led to rapid visual recovery.

Adult↗

PubMed2007

Pupil dilation with intracameral lidocaine during phacoemulsification.

PURPOSE: To evaluate pupil dilation by an intracameral injection of nonpreserved lidocaine 1% during phacoemulsification cataract extraction and compare the results with those using conventional topical mydriatics. SETTING: Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. METHODS: A prospective comparative case series study was conducted. The study included 57 patients who were given topical mydriatics (30 eyes) or intracameral lidocaine (27 eyes) to dilate the pupil for phacoemulsification and intraocular lens implantation. The topical group received 3 drops of cyclopentolate 1% and phenylephrine 5% given 5 minutes apart starting 60 minutes before surgery. The intracameral group received preservative-free lidocaine 1% (0.2 to 0.3 mL) injected just before the procedure began. No epinephrine was added to the irrigating solution. In both groups, the horizontal pupil diameter was measured before and after pupil dilation using the same caliper. Total surgical time, need for a mydriatic agent during the procedure, and subjective surgical performance were recorded. RESULTS: The mean age, sex, cataract density, baseline horizontal pupil diameter, and mean duration of the surgery were the same between the topical group and intracameral group. The mean pupil dilation was 4.52 mm +/- 0.08 (SD) in the intracameral group and 4.06 +/- 0.09 mm in the topical group; the difference between groups was statistically significant (P = .001). There was no significant difference between groups in the overall subjective surgical performance (P = .74). No patient in the intracameral group and 2 patients in the topical group required an intracameral mydriatic injection. CONCLUSION: During phacoemulsification, intracameral preservative-free lidocaine 1% provided rapid, effective mydriasis comparable that of topical mydriatics.

Aged↗

PubMed1997

Phacoemulsification procedures performed with topical anesthesia.

Phacoemulsification procedures with topical anesthesia, performed with small corneal incisions and 4% lidocaine hydrochloride methylparaben-free eye drops, have very high patient satisfaction rates because patients do not experience intraoperative pain, do not require sutures or eye patches, and have immediate improvements in their vision. Phacoemulsification procedures with topical anesthesia are cost-effective for surgery departments because patients have shorter hospitalizations and require fewer chargeable items. The perioperative nursing role is essential to the success of phacoemulsification procedures with topical anesthesia.

Anesthesia, Local↗

PubMed2001

Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis.

PURPOSE: This study reports outcomes of phacoemulsification cataract extraction and posterior chamber intraocular lens implantation within the capsular bag in patients with uveitis. METHODS: We retrospectively reviewed the charts of 32 patients (39 eyes) with uveitis who underwent phacoemulsification cataract extraction and posterior chamber intraocular lens implantation by two surgeons at The Cleveland Clinic Foundation from January 1990 to June 1998. Patients with less than 3 months of follow-up were excluded. RESULTS: Diagnoses of uveitis included idiopathic (15 eyes), sarcoidosis (10 eyes), pars planitis (four eyes), CMV retinitis (two eyes), Fuchs heterochromic iridocyclitis (two eyes), syphilis (two eyes), and one eye each of tuberculosis, Crohn's disease, HLA-B27 associated, and acute retinal necrosis. Average follow-up was 20 months (range, 3 to 63 months). Best-corrected visual acuity improved in 37 eyes (95%). Average improvement was 4 +/- 3 Snellen acuity lines (range, 1 to 10 lines). Thirty-four eyes (87%) attained final visual acuity better than or equal to 20/40. Visual loss occurred in one eye (3%) with CMV retinitis. No improvement in visual acuity was seen in one eye (3%) that developed a retinal pigment epithelial detachment. Posterior capsule opacification occurred in 24 eyes (62%), 12 of which required Nd:YAG capsulotomy (31%). Other postoperative complications included recurrence of uveitis (41%), cystoid macular edema (33%), epiretinal membrane formation (15%), and posterior synechiae (8%). CONCLUSIONS: Phacoemulsification cataract extraction with posterior chamber intraocular lens implantation is safe in patients with uveitis. The incidences of recurrence of uveitis, cystoid macular edema, epiretinal membrane, and posterior synechiae were lower than those reported previously for extracapsular cataract extraction.

Adult↗

PubMed2003

Retinal detachment rate after vitrectomy for retained lens material after phacoemulsification.

PURPOSE: To report the rate of retinal detachment after vitrectomy for retained intravitreal lens material after phacoemulsification using specific vitrectomy techniques designed to minimize retinal detachment. DESIGN: Consecutive, interventional case series. METHODS: Retrospective chart review of 100 consecutive eyes (one surgeon) of 100 patients undergoing vitrectomy for retained lens material after phacoemulsification and followed up for 3 months or longer unless an outcome event had occurred. Vitrectomy techniques employed to minimize the frequency of retinal detachment included inducing posterior vitreous detachment with maximal vitreous removal before phacofragmentation to avoid vitreous trauma, lens fragment debulking before fragmentation, use of low energy with high aspiration during removal of retained lens material, and intraoperative indirect ophthalmoscopic evaluation of the retinal periphery with scleral indentation to diagnose and treat intraoperative retinal breaks. The main outcome measures included prevalence of coexisting retinal detachment in eyes with retained lens material, incidence of retinal detachment or retinal breaks after vitrectomy for removal of retained lens material, and final visual acuity. RESULTS: The prevalence of previtrectomy retinal detachment was 4%; the incidence of postvitrectomy retinal detachment was 4%; the final visual acuity was 20/40 or better in 53%. One patient had a retinal break recognized during vitrectomy and was treated with retinocryopexy, but postoperative retinal detachment developed from a separate break. Three others were treated during vitrectomy for retinal breaks (including two with known preexisting breaks) and did not have any retinal detachment. Poor previtrectomy visual acuity (hand motions) was a risk factor for postvitrectomy retinal detachment. CONCLUSIONS: The rate of retinal detachment reported after vitrectomy for retained lens material after phacoemulsification can be minimized to approximately the rate expected with cataract extraction complicated by vitreous loss by employing standard surgical techniques. Higher risk eyes may benefit from more frequent postvitrectomy examinations.

Aged↗